A new study explores how 'essentially placebo' treatments raise questions about the transparency and trust that underpin the doctor-patient relationship.
‘We’re entering a new era,’ said Dr. Maximilian Konig, a rheumatologist at Johns Hopkins University who’s studying some of the possible new treatments. They offer ‘the chance to control disease in a way we’ve never seen before.’
Pay disparities related to gender, race and immigration status persist among Canadian doctors and are tied to physician responses to patient expectations.
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic.
